Xtant Medical Holdings, Inc.

XTNT · XNYS

CIK 1453593fmd_154YZ6WP1WQHD9H62YFH5KVJZ5Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2010 to Jun 30, 2026, 65 periods

Income Statement · Annual · Millions · USD
Line item	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	90	83	72	65	53	55	58	91	117	134
Cost of revenue	28	33	29	22	19	23	26	36	49	50
Gross profit	62	50	43	43	34	32	32	55	68	84
Research and development	3	2	2	1	1	1	1	1	2	2
Selling, general and administrative	60	56	46	44	34	35	38	64	78	75
Total operating expenses	70	88	104	45	35	36	39	66	80	77
Operating income	(8)	(38)	(60)	(2)	(1)	(4)	(7)	(10)	(12)	7
Interest expense	12	15	10	6	6	1	2	3	4	4
Interest and investment income	–	–	–	–	–	–	0	0	–	0
Other non-operating income (expense)	(12)	(15)	(10)	(6)	(6)	(1)	(2)	9	(4)	(0)
Income before taxes	(19)	(52)	(70)	(8)	(7)	(5)	(8)	(1)	(16)	7
Income tax expense	0	0	–	0	0	–	0	(2)	0	2
Net income from continuing operations	(19)	(52)	–	(8)	(7)	–	(8)	1	(16)	5
Net income	(19)	(52)	(70)	(8)	(7)	(5)	(8)	1	(16)	5